ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,309, issued on April 7, was assigned to -International N&H Denmark Aps (Kongens Lyngby, Denmark).
"Bifidobacteria for treating diabetes and related conditions" was invented by Remy Burcelin (Escalquens, France), Didier Carcano (Paris) and Sampo Lahtinen (Lohja, Finland).
According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to new uses of Bifidobacteria (particularly, although not exclusively, probiotic Bifidobacteria), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of diabetes (particularly Type 2 diabetes), obesity and related condi...